1. Academic Validation
  2. Nexinhib20 Inhibits Neutrophil Adhesion and β2 Integrin Activation by Antagonizing Rac-1-Guanosine 5'-Triphosphate Interaction

Nexinhib20 Inhibits Neutrophil Adhesion and β2 Integrin Activation by Antagonizing Rac-1-Guanosine 5'-Triphosphate Interaction

  • J Immunol. 2022 Oct 15;209(8):1574-1585. doi: 10.4049/jimmunol.2101112.
Wei Liu 1 Chunxia G Cronin 2 Ziming Cao 1 Chengliang Wang 1 Jianbin Ruan 1 Sunitha Pulikkot 1 Alexxus Hall 1 Hao Sun 3 Alex Groisman 4 Yunfeng Chen 5 6 Anthony T Vella 1 Liang Hu 7 Bruce T Liang 8 Zhichao Fan 9 10
Affiliations

Affiliations

  • 1 Department of Immunology, School of Medicine, UConn Health, Farmington, CT.
  • 2 Pat and Jim Calhoun Cardiology Center, School of Medicine, UConn Health, Farmington, CT.
  • 3 Department of Medicine, University of California San Diego, La Jolla, CA.
  • 4 Department of Physics, University of California San Diego, La Jolla, CA.
  • 5 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX.
  • 6 Department of Pathology, University of Texas Medical Branch, Galveston, TX.
  • 7 Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China; and.
  • 8 Pat and Jim Calhoun Cardiology Center, School of Medicine, UConn Health, Farmington, CT; zfan@uchc.edu bliang@uchc.edu.
  • 9 Department of Immunology, School of Medicine, UConn Health, Farmington, CT; zfan@uchc.edu bliang@uchc.edu.
  • 10 Division of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA.
Abstract

Neutrophils are critical for mediating inflammatory responses. Inhibiting neutrophil recruitment is an attractive approach for preventing inflammatory injuries, including myocardial ischemia-reperfusion (I/R) injury, which exacerbates cardiomyocyte death after primary percutaneous coronary intervention in acute myocardial infarction. In this study, we found out that a neutrophil exocytosis inhibitor Nexinhib20 inhibits not only exocytosis but also neutrophil adhesion by limiting β2 Integrin activation. Using a microfluidic chamber, we found that Nexinhib20 inhibited IL-8-induced β2 integrin-dependent human neutrophil adhesion under flow. Using a dynamic flow cytometry assay, we discovered that Nexinhib20 suppresses intracellular calcium flux and β2 Integrin activation after IL-8 stimulation. Western blots of Ras-related C3 botulinum toxin substrate 1 (Rac-1)-GTP pull-down assays confirmed that Nexinhib20 inhibited Rac-1 activation in leukocytes. An in vitro competition assay showed that Nexinhib20 antagonized the binding of Rac-1 and GTP. Using a mouse model of myocardial I/R injury, Nexinhib20 administration after ischemia and before reperfusion significantly decreased neutrophil recruitment and infarct size. Our results highlight the translational potential of Nexinhib20 as a dual-functional neutrophil inhibitory drug to prevent myocardial I/R injury.

Figures
Products